Syneos Health, Inc. (SYNH) Tops Q2 EPS by 1c, Offers FY Guidance

Syneos Health, Inc. (NASDAQ: SYNH) reported Q2 EPS of $0.97, $0.01 better than the analyst estimate of $0.96. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.27 billion.

GUIDANCE:

Syneos Health, Inc. sees FY2021 EPS of $4.25-$4.43, versus the consensus of $4.31. Syneos Health, Inc. sees FY2021 revenue of $5.18-5.3 billion, versus the consensus of $5.21 billion.

For earnings history and earnings-related data on Syneos Health, Inc. (SYNH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance